Standardization And Quality Control Of Breast Biopsy Needle Types: Full-Chain Standardization From Production To Clinical Use

https://www.mayoclinic.org/tests-procedures/breast-biopsy/about/pac-20384812

As a Class III medical device, the classification of breast biopsy needles is not only a technical classification but also the foundation for quality control and supervision. From raw material procurement to clinical use, different types of biopsy needles must adhere to a strict standard system to ensure diagnostic accuracy and patient safety.

Standardization in the production process is the first line of defense in quality control. Taking stainless steel biopsy needles as an example, they must comply with ISO 7153-1 "Surgical instruments - Metallic materials - Part 1: Stainless steel". The chromium content of the needle body material must be no less than 17%, and the nickel content must be controlled between 10% and 14% to ensure corrosion resistance. Needle tip sharpness is a core indicator-according to the test method of YY/T 0583 "Disposable Sterile Syringes", the biopsy needle must be able to easily penetrate simulated tissue (such as pigskin or polyurethane foam), with a puncture force not exceeding 5N. For disposable biopsy needles, they must also pass the ethylene oxide residue test (≤10μg/g) and a sterility test (performed according to GB/T 14233.2).

The performance evaluation system is differentiated for different types of biopsy needles. For example, hollow needle biopsy requires evaluation of tissue retrieval rate (≥90%), tissue integrity (no compression deformation), and diagnostic accuracy (compared with surgical pathology results); fine needle puncture focuses on assessing cell retrieval volume (≥500 cells per smear) and smear pass rate (no blood contamination). Vacuum-assisted biopsy needles also require testing for negative pressure stability (maintaining -80kPa negative pressure for ≥30 seconds) and cutting speed (single cutting time ≤0.5 seconds).

Clinical usage guidelines are equally important. The "Guidelines for Breast Imaging-Guided Interventional Therapy" published by the Chinese Society of Radiology clearly states that: 14G-16G automated biopsy needles are recommended for ultrasound-guided biopsy, with the insertion angle and probe angle maintained at 30°-45°; 11G-13G vacuum-assisted biopsy needles should be used for stereotactic mammography, with an insertion depth error ≤5mm. For reusable biopsy needles, the guidelines require the establishment of a "one needle, one file" traceability system, recording the number of cleaning, disinfection, and sterilization cycles and performance test results. Needles exceeding 100 uses or exhibiting blunted tips or spring failure must be discarded.

The unification of international standards is also accelerating. The ISO 13485 quality management system requires biopsy needle manufacturers to establish risk management processes to assess and control potential risks (such as breakage, infection, and positioning deviation) for different types of products. The EU's MDR (Maintenance, Diagnosis, and Treatment) regulations classify biopsy needles into Class IIa (fine-needle aspiration) and Class IIb (vacuum-assisted biopsy) based on risk level, implementing stricter post-market surveillance (PMS) requirements.

Standardization and strengthened quality control are driving a shift in breast biopsy needle types from "experience-driven" to "data-driven," providing patients with safer and more reliable diagnostic and treatment options.